Skip to content
Recall Observatory FDA recall evidence

Drug product

Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch

D-0474-2026

March 19, 2026

Class II

Product summary

Firm
Teva Pharmaceuticals USA, Inc
Event
Event 98614
Status
Ongoing
Classification
Class II
Quantity
113,943 Cartons
Official record key
drug-enforcement:D-0474-2026

Official wording

Reason: CGMP Deviations: use of an unapproved raw material

Code information: Lot: 100053892, Exp.: 04/2026; 100057899, Exp.: 05/2026; 100062704, Exp.: 02/2027.

Distribution pattern: Within U.S

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations